To further substantiate this hypothesis, we selected three more pancreatic cancer cell lines BxPC-3 (non-metastatic), AsPC-1 (invasive), and SW1990 (metastatic) for performing NFATc1 loss and gain-of-function experiments. This evidence concerns the gene NFATC1 and pancreatic neoplasm.